Design, synthesis and biological evaluation of mitochondria targeting theranostic agents

Area of Science:

• Mitochondrial research
• Medicinal chemistry
• Theranostics

Background:

• Mitochondria play a crucial role in cellular functions and disease.
• Targeting mitochondria offers a promising strategy for developing novel therapeutics.
• Developing effective mitochondria-targeting agents remains a challenge.

Purpose of the Study:

• To design and synthesize novel dual mitochondria targeting fluorescent analogues.
• To evaluate the uptake and cytotoxicity of these novel compounds.
• To identify promising candidates for mitochondria-targeted theranostic applications.

Main Methods:

• Chemical synthesis of F16-TPP analogues.
• Mitochondrial uptake studies using fluorescence microscopy.
• Cytotoxicity assays to determine compound efficacy and safety.

Main Results:

• Successfully designed and synthesized novel dual mitochondria targeting fluorescent F16-TPP analogues.
• Compounds FF16 and FF16-TPP demonstrated significant uptake into mitochondria.
• FF16 and FF16-TPP exhibited promising cytotoxicity profiles.

Conclusions:

• The designed F16-TPP analogues effectively target mitochondria.
• FF16 and FF16-TPP represent promising mitochondria-targeting theranostic agents.
• Further investigation is warranted to explore their therapeutic potential.